Celator Pharmaceuticals

Healthcare 📍 Princeton, United States 👥 11-50 employees 💰 $96.9M raised 📅 Founded 1999

Celator Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies to treat cancer. The company focuses on CombiPlex, a drug ratio technology platform that enables to the development of combination therapies. Its products include CPX-1 (Irinotecan HCI-Floxuridine), a treatment for colorectal cancer; and CPX

🌐 Website in LinkedIn ← All Companies

📊 Company Overview

Sector

Healthcare

Country

United States

Employees

11-50

Total Raised · Private Equity

$96.9M

Founded

1999

Cloud

Unknown

Email

Proofpoint

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider

Workspace	Proofpoint
CDN	🔒 Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$108K – $270K / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms	🔒 Subscribers only
Analytics & CRM	🔒 Subscribers only
CMS / Platform	🔒 Subscribers only
Frontend Stack	🔒 Subscribers only

Detected from Celator Pharmaceuticals's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

1-10 ☁️ Unknown

Central Printing Group

1-10 ☁️ Unknown

Ortho Clinical Diagnostics Holdings Plc

1-10 ☁️ Azure

Data detected 2026-06-13 · Methodology · Suggest a correction